会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PHARMACEUTICAL COMPOSITION OF AN IONTOPHORESIS
    • 药物的药物组合物
    • US20120165782A1
    • 2012-06-28
    • US13388295
    • 2010-07-28
    • Akihiro HasuiTakamitsu Miyagi
    • Akihiro HasuiTakamitsu Miyagi
    • A61K31/661A61P29/00A61N1/30A61P21/00A61P15/02A61K9/00A61P19/02
    • A61K31/573A61K9/0009A61K47/18A61K47/32A61N1/0428A61N1/0432A61N1/0448A61N1/30
    • It is an object of the present inventions to produce a pharmaceutical composition for the iontophoresis wherein a drug stability is excellent, and it is easy to blend and fill up when manufactured and it is possible to manufacture at low cost. A pharmaceutical composition for an iontophoresis according to the present invention, is characterized in that the composition contains a nonionic synthetic polymer, betamethasone sodium phosphate and solvent. Furthermore, in a preferred embodiment of a pharmaceutical composition for an iontophoresis according to the present invention, the composition is characterized in that the nonionic synthetic polymer is polyvinyl alcohol (PVA). Furthermore, in a preferred embodiment of a pharmaceutical composition for an iontophoresis according to the present invention, the composition is characterized in that the mixing amount of the polyvinyl alcohol (PVA) is 0.5 to 30.0 percent by weight.
    • 本发明的目的是制备用于离子电渗疗法的药物组合物,其中药物稳定性优异,并且在制造时容易混合和填充,并且可以以低成本制造。 根据本发明的用于离子电渗疗法的药物组合物的特征在于,所述组合物含有非离子合成聚合物,倍他米松磷酸钠和溶剂。 此外,在本发明的离子电渗疗法用药物组合物的优选实施方式中,所述组合物的特征在于,所述非离子型合成聚合物为聚乙烯醇(PVA)。 此外,在本发明的离子电渗用药物组合物的优选实施方式中,所述组合物的特征在于,所述聚乙烯醇(PVA)的混合量为0.5〜30.0重量%。
    • 2. 发明授权
    • Pharmaceutical composition of an iontophoresis
    • 离子电渗疗法的药物组成
    • US08652522B2
    • 2014-02-18
    • US13388295
    • 2010-07-28
    • Akihiro HasuiTakamitsu Miyagi
    • Akihiro HasuiTakamitsu Miyagi
    • A61K9/14A61N1/30
    • A61K31/573A61K9/0009A61K47/18A61K47/32A61N1/0428A61N1/0432A61N1/0448A61N1/30
    • It is an object of the present inventions to produce a pharmaceutical composition for the iontophoresis wherein a drug stability is excellent, and it is easy to blend and fill up when manufactured and it is possible to manufacture at low cost. A pharmaceutical composition for an iontophoresis according to the present invention, is characterized in that the composition contains a nonionic synthetic polymer, betamethasone sodium phosphate and solvent. Furthermore, in a preferred embodiment of a pharmaceutical composition for an iontophoresis according to the present invention, the composition is characterized in that the nonionic synthetic polymer is polyvinyl alcohol (PVA). Furthermore, in a preferred embodiment of a pharmaceutical composition for an iontophoresis according to the present invention, the composition is characterized in that the mixing amount of the polyvinyl alcohol (PVA) is 0.5 to 30.0 percent by weight.
    • 本发明的目的是制备用于离子电渗疗法的药物组合物,其中药物稳定性优异,并且在制造时容易混合和填充,并且可以以低成本制造。 根据本发明的用于离子电渗疗法的药物组合物的特征在于,所述组合物含有非离子合成聚合物,倍他米松磷酸钠和溶剂。 此外,在本发明的离子电渗疗法用药物组合物的优选实施方式中,所述组合物的特征在于,所述非离子型合成聚合物为聚乙烯醇(PVA)。 此外,在本发明的离子电渗用药物组合物的优选实施方式中,所述组合物的特征在于,所述聚乙烯醇(PVA)的混合量为0.5〜30.0重量%。
    • 3. 发明授权
    • Iontophoresis patch
    • 离子电渗贴片
    • US09517331B2
    • 2016-12-13
    • US13578168
    • 2011-02-09
    • Mitsutoshi YaegashiAkihiro HasuiHiroyuki Kubo
    • Mitsutoshi YaegashiAkihiro HasuiHiroyuki Kubo
    • A61N1/30A61N1/04
    • A61N1/0428
    • An iontophoresis patch is equipped with a donor gel and a reference gel which are disposed to contact an external conductor, for example, the skin of a patient and thereby output current from a current-carrying device to the external conductor. The iontophoresis patch includes: a donor portion having the donor gel containing a medical agent to be penetrated into the external conductor; a reference portion having a reference gel, mounted with the current-carrying device on the surface on the side opposite to the reference gel, and disposed on the external conductor apart from the donor portion; and an electrode film for supplying current from the current-carrying device to the donor gel and the reference gel.
    • 离子电渗贴片配备有供体凝胶和参考凝胶,其被设置为接触外部导体,例如患者的皮肤,从而将电流从载流装置输出到外部导体。 离子电渗贴片包括:供体部分,其具有供体凝胶,其含有要渗入外导体的药剂; 具有参考凝胶的参考部分,其在与参考凝胶相反的一侧的表面上安装有载流装置,并且设置在远离供体部分的外部导体上; 以及用于从载流装置向供体凝胶和参考凝胶提供电流的电极膜。
    • 4. 发明申请
    • IONTOPHORESIS PATCH
    • IOPOPHORESIS PATCH
    • US20120310143A1
    • 2012-12-06
    • US13578168
    • 2011-02-09
    • Mitsutoshi YaegashiAkihiro HasuiHiroyuki Kubo
    • Mitsutoshi YaegashiAkihiro HasuiHiroyuki Kubo
    • A61N1/30
    • A61N1/0428
    • An iontophoresis patch is equipped with a donor gel and a reference gel which are disposed to contact an external conductor, for example, the skin of a patient and thereby output current from a current-carrying device to the external conductor. The iontophoresis patch includes: a donor portion having the donor gel containing a medical agent to be penetrated into the external conductor; a reference portion having a reference gel, mounted with the current-carrying device on the surface on the side opposite to the reference gel, and disposed on the external conductor apart from the donor portion; and an electrode film for supplying current from the current-carrying device to the donor gel and the reference gel.
    • 离子电渗贴片配备有供体凝胶和参考凝胶,其被设置为接触外部导体,例如患者的皮肤,从而将电流从载流装置输出到外部导体。 离子电渗贴片包括:供体部分,其具有供体凝胶,其含有要渗入外导体的药剂; 具有参考凝胶的参考部分,其在与参考凝胶相反的一侧的表面上安装有载流装置,并且设置在远离供体部分的外部导体上; 以及用于从载流装置向供体凝胶和参考凝胶提供电流的电极膜。
    • 8. 发明授权
    • Electrode device used in iontophoresis treatment
    • 用于离子电渗疗法的电极装置
    • US09433772B2
    • 2016-09-06
    • US13518343
    • 2010-12-17
    • Akihiro Hasui
    • Akihiro Hasui
    • A61N1/30A61N1/04
    • A61N1/0448A61N1/0432
    • The present invention provides an electrode device used in iontophoresis treatment, in which an electrode layer used for introduction of medication can be contacted to a medication reservoir layer with a simple manner, and in which the medication reservoir layer can be reliably held when the medication is introduced into a skin. A main-electrode layer 3 and a sub-electrode layer 1 are secured on a substrate 6 while both the layers are being insulated from each other. The main-electrode layer 3 is intended for introduction of the medication, and the sub-electrode layer 1 is provided to hold the medication reservoir layer 5 on the substrate 6. The medication reservoir layer 5 is located on the substrate 6, so as to be in contact with the main-electrode layer 3 and the sub-electrode layer 1. The medication reservoir layer 5 is a gel containing halogen compound, and the sub-electrode layer 1 comprises a metal having a lower ionization tendency than hydrogen. The medication reservoir layer 5 and the sub-electrode layer 1 are bonded to each other by applying an electric current to both layers. In this way, the medication reservoir layer 5 can be firmly held on the substrate 6, while being kept in contact with the main-electrode layer 3.
    • 本发明提供一种用于离子电渗处理的电极装置,其中用于引入药物的电极层可以以简单的方式与药物储存层接触,并且其中当药物是药物储存层时可以可靠地保持药物储存层 引入皮肤。 主电极层3和副电极层1固定在基板6上,同时两层彼此绝缘。 主电极层3用于引入药物,并且设置副电极层1以将药物储存层5保持在基板6上。药物储存层5位于基板6上,以便 与主电极层3和副电极层1接触。药物储存层5是含有卤素化合物的凝胶,副电极层1具有比氢更低的电离倾向的金属。 药物储存层5和副电极层1通过向两层施加电流而彼此接合。 以这种方式,药物储存层5能够牢固地保持在基板6上,同时与主电极层3保持接触。
    • 9. 发明申请
    • ELECTRODE DEVICE USED IN IONTOPHORESIS TREATMENT
    • 电极设备用于静电治疗
    • US20120330217A1
    • 2012-12-27
    • US13518343
    • 2010-12-17
    • Akihiro Hasui
    • Akihiro Hasui
    • A61N1/30
    • A61N1/0448A61N1/0432
    • The present invention provides an electrode device used in iontophoresis treatment, in which an electrode layer used for introduction of medication can be contacted to a medication reservoir layer with a simple manner, and in which the medication reservoir layer can be reliably held when the medication is introduced into a skin. A main-electrode layer 3 and a sub-electrode layer 1 are secured on a substrate 6 while both the layers are being insulated from each other. The main-electrode layer 3 is intended for introduction of the medication, and the sub-electrode layer 1 is provided to hold the medication reservoir layer 5 on the substrate 6. The medication reservoir layer 5 is located on the substrate 6, so as to be in contact with the main-electrode layer 3 and the sub-electrode layer 1. The medication reservoir layer 5 is a gel containing halogen compound, and the sub-electrode layer 1 comprises a metal having a lower ionization tendency than hydrogen. The medication reservoir layer 5 and the sub-electrode layer 1 are bonded to each other by applying an electric current to both layers. In this way, the medication reservoir layer 5 can be firmly held on the substrate 6, while being kept in contact with the main-electrode layer 3.
    • 本发明提供一种用于离子电渗处理的电极装置,其中用于引入药物的电极层可以以简单的方式接触药物储存层,并且其中当药物是药物储存层时可以可靠地保持药物储存层 引入皮肤。 主电极层3和副电极层1固定在基板6上,同时两层彼此绝缘。 主电极层3用于引入药物,并且设置副电极层1以将药物储存层5保持在基板6上。药物储存层5位于基板6上,以便 与主电极层3和副电极层1接触。药物储存层5是含有卤素化合物的凝胶,副电极层1具有比氢更低的电离倾向的金属。 药物储存层5和副电极层1通过向两层施加电流而彼此接合。 以这种方式,药物储存层5能够牢固地保持在基板6上,同时与主电极层3保持接触。